| n | Group | Men | value | Women | value | Alcoholic cirrhosis | NAFLD cirrhosis | Alcoholic cirrhosis | NAFLD cirrhosis | N = 195 | N = 56 | N = 85 | N = 49 |
| Age, years | | 58.00 (48.88, 63.03) | 62.47 (57.50, 67.14) | 0.002 | 55.36 (47.47, 61.27) | 61.97 (53.91, 67.00) | 0.006 | Body mass index (kg/m2) | | 27.04 (23.54, 30.41) | 29.54 (26.62, 33.58) | 0.001 | 24.24 (21.87, 27.90) | 26.78 (24.61, 35.75) | <0.001 | Obese, n (%) | | 54 (27.7) | 24 (42.9) | | 14 (16.5) | 20 (40.8) | 0.003 | Mid-arm circumference (cm) | | 26.50 (24.00, 30.00) | 29.00 (26.75, 33.00) | <0.001 | 24.00 (22.00, 27.00) | 27.00 (24.00, 30.00) | <0.001 | Tricipital skinfold (mm) | | 9.00 (6.00, 14.00) | 12.20 (7.15, 18.80) | 0.016 | 11.00 (7.00, 17.00) | 17.20 (9.40, 24.00) | 0.005 | Mid-arm muscle area (cm2) | | 41.79 (35.67, 50.44) | 51.18 (40.69, 63.06) | 0.001 | 34.16 (27.37, 42.50) | 39.55 (32.94, 49.88) | 0.006 | Hand grip strength (kg) | | 26.27 (21.37, 32.50) | 29.07 (24.71, 34.39) | 0.018 | 14.83 (11.07, 17.83) | 17.03 (12.43, 19.93) | 0.194 | Low hand grip strength, n (%) | | 127 (65.1) | 30 (53.6) | 0.12 | 71 (83.5) | 37 (75.5) | 0.267 | Chair stands/s | | 0.36 (0.28, 0.43) | 0.44 (0.35, 0.51) | 0.004 | 0.35 (0.26, 0.42) | 0.30 (0.22, 0.41) | 0.398 | Chair stands categories, n (%) | Normal | 18 (9.2) | 12 (21.4) | 0.044 | 5 (5.9) | 4 (8.2) | 0.881 | Low | 110 (56.4) | 30 (53.6) | | 49 (57.6) | 27 (55.1) | | Unable to stand | 67 (34.4) | 14 (25.0) | | 31 (36.5) | 18 (36.7) | | Equilibrum total time (s) | | 30.00 (20.00, 30.00) | 30.00 (27.07, 30.00) | 0.077 | 30.00 (13.00, 30.00) | 30.00 (20.00, 30.00) | 0.448 | Equilibrum categories, n (%) | Normal | 118 (60.5) | 40 (71.4) | 0.353 | 47 (55.3) | 28 (57.1) | 0.607 | Low | 55 (28.2) | 12 (21.4) | | 22 (25.9) | 15 (30.6) | | Unable to stand | 22 (11.3) | 4 (7.1) | | 16 (18.8) | 6 (12.2) | | Liver frailty index (LFI) | | 4.37 (3.91, 4.95) | 4.05 (3.59, 4.68) | 0.004 | 4.67 (4.15, 5.40) | 4.65 (4.03, 4.96) | 0.590 | LFI > 80th percentile = 5.2, n (%) | | 35 (17.9) | 5 (8.9) | 0.146 | 25 (29.4) | 9 (18.4) | 0.216 | LFI > 4.5 | | 87 (44.6) | 18 (32.1) | 0.124 | 47 (55.3) | 32 (65.3) | 0.279 | Serum bilirubin (umol/l) | | 46.8 (24.8, 113.7) | 25.0 (19.9, 46.7) | 0.001 | 75.5 (29.3, 164.9) | 27.2 (18.3, 124.4) | 0.01 | Serum albumin (g/l) | | 28.00 (24.61, 32.00) | 31.00 (26.75, 37.25) | 0.002 | 29.00 (24.00, 34.00) | 28.90 (27.00, 32.00) | 0.989 | Serum creatinine (umol/l) | | 81.00 (62.00, 119.00) | 83.00 (66.75, 118.25) | 0.433 | 74.00 (54.00, 99.00) | 71.00 (54.00, 94.10) | 0.948 | C-reactive protein (mg/l) | | 14.52 (6.83, 34.20) | 8.73 (4.16, 17.75) | 0.010 | 25.29 (7.16, 50.33) | 14.61 (6.28, 29.14) | 0.122 | White blood cells (∗109/l) | | 6.80 (4.80, 10.60) | 5.50 (4.00, 7.32) | 0.001 | 8.00 (5.40, 12.56) | 6.50 (3.70, 8.10) | 0.003 | MELD-Na score | | 18.89 (13.73, 24.00) | 14.50 (11.00, 18.50) | <0.001 | 19.00 (14.00, 25.00) | 15.00 (11.00, 20.00) | 0.010 | Child-Pugh-Turcotte score | | 9.00 (7.00, 11.00) | 8.00 (6.00, 9.00) | <0.001 | 10.00 (8.00, 11.00) | 9.00 (7.00, 10.00) | 0.045 | Refractory ascites, n (%) | | 68 (36.4) | 13 (23.2) | 0.076 | 21 (25.6) | 10 (21.3) | 0.671 | Event during follow-up, n (%) | None, LT, death | 95, 5, 22 (48.7, 5.1, 46.2) | 29, 5, 22 (51.8, 8.9, 39.3) | 0.413 | 50, 4, 31 (58.8, 4.7, 36.5) | 23, 2, 24 (46.9, 4.1, 49.0) | 0.383 |
|
|